Published in Lab Invest on October 01, 1984
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev (1995) 1.90
Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol (1989) 1.65
Clonal characteristics of posttransplant lymphoproliferative disorders. Transplant Proc (1988) 0.86
Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases. Environ Health Perspect (1990) 0.83
Depressed maternal lymphocyte response to phytohaemagglutinin in human pregnancy. Lancet (1972) 4.47
Fatal strongyloidiasis in immunosuppressed patients. Am J Med (1974) 2.76
Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol (1987) 2.74
X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet (1975) 2.57
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. N Engl J Med (1977) 2.01
Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev (1988) 1.78
Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood (2000) 1.78
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res (1981) 1.72
Rapid detection of cytomegalovirus by tissue culture, centrifugation, and immunofluorescence with a monoclonal antibody to an early nuclear antigen. J Virol Methods (1987) 1.63
Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP) Cancer Genet Cytogenet (1990) 1.58
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood (1987) 1.56
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53
Hematopathologic features of Epstein-Barr virus-induced human B-lymphoproliferation in mice with severe combined immunodeficiency. A model of lymphoproliferative diseases in immunocompromised patients. Lab Invest (1991) 1.48
Letter: Fatal infectious mononucleosis in familial lymphohistiocytosis. N Engl J Med (1974) 1.46
Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. Int Rev Exp Pathol (1985) 1.35
Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome. Lancet (1978) 1.27
Cirrhosis and hepatoma occurring at Boston City Hospital (1917-1968). Cancer (1973) 1.26
Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. Science (1980) 1.25
Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals. Lancet (1980) 1.24
Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. Am J Med (1982) 1.23
Immunological bases for superior survival of females. Am J Dis Child (1979) 1.22
Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects. J Immunol (1982) 1.20
Acquired immunodeficiency syndrome, opportunistic infections, and malignancies in male homosexuals. A hypothesis of etiologic factors in pathogenesis. JAMA (1983) 1.20
Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev (1991) 1.19
Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome. Semin Hematol (1979) 1.15
Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Am J Med Genet (1991) 1.15
X-linked lymphoproliferative syndrome registry report. J Pediatr (1980) 1.13
Hepatitis in fatal infectious mononucleosis. Gastroenterology (1987) 1.11
Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV). J Immunol Methods (1986) 1.11
Chronic mononucleosis syndrome. South Med J (1984) 1.09
Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections. Pathol Annu (1980) 1.07
Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood (1988) 1.06
Cystic fibrosis complicated by acute leukemia. Cancer (1986) 1.05
Immunodeficiency to the Epstein-Barr virus in the X-linked recessive lymphoproliferative syndrome. Clin Immunol Immunopathol (1978) 1.05
Pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome. Lancet (1976) 1.04
Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med (1987) 1.03
Primary hepatic malignancy in pregnant women. Am J Obstet Gynecol (1975) 1.03
Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects. J Immunol (1982) 1.02
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies. Cancer Res (1981) 1.01
Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome. Arch Pathol Lab Med (1985) 0.99
Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. J Immunol (1980) 0.99
Impact of cool temperatures on transformation of human and armadilio lymphocytes (Dasypus novemcinctus, Linn.) as related to leprosy. Nature (1974) 0.99
Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. Am J Pathol (1990) 0.99
Epstein-Barr virus: the spectrum of its manifestations in human beings. South Med J (1987) 0.98
Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis. Mod Pathol (1991) 0.97
Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-alpha. Clin Immunol Immunopathol (1990) 0.96
Onchocerciasis presenting with swelling of limb. Am J Trop Med Hyg (1974) 0.96
Hematopathology and Pathogenesis of the X-linked recessive lymphoproliferative syndrome. Am J Med (1977) 0.96
Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med (1987) 0.96
Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. Am J Pathol (1991) 0.95
Adenovirus infection in patients with Kawasaki disease. J Med Virol (1990) 0.94
Lobomycosis. An electronmicroscopic, histochemical and immunologic study. J Cutan Pathol (1976) 0.93
Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma. IARC Sci Publ (1985) 0.92
The Epstein-Barr virus (EBV) in the pathogenesis of posttransplant lymphoma. Transplant Proc (1981) 0.92
Introduction to Epstein-Barr virus and lymphoproliferative diseases in immunodeficient individuals. Cancer Res (1981) 0.92
Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer (1987) 0.92
Fulminant liver failure induced by adenovirus after bone marrow transplantation. N Engl J Med (1985) 0.91
Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. Adv Cancer Res (1981) 0.91
Fatal infections in protein-calorie malnourished children with thymolymphatic atrophy. Arch Dis Child (1975) 0.91
Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk. J Immunol (1982) 0.89
A multifactorial model for the development of AIDS in homosexual men. Ann N Y Acad Sci (1984) 0.89
Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. Cancer Res (1988) 0.89
Adenovirus type-2 in a patient with lethal hemorrhagic colonic ulcers and chronic active Epstein-Barr virus infection. Ann Intern Med (1988) 0.89
Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village. AIDS Res (1986) 0.88
Cellular immune defects to Epstein-Barr virus-determined antigens in young males. Cancer Res (1981) 0.87
X-linked lymphoproliferative syndrome: abnormal antibody responses to bacteriophage phi X 174. Birth Defects Orig Artic Ser (1983) 0.86
Pigeon breeders' disease: immunofluorescent localization of sensitizing antigens in pigeon. Clin Immunol Immunopathol (1975) 0.86
Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21). J Natl Cancer Inst (1988) 0.86
Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia. Int J Cancer (1981) 0.85
Sera of patients with hairy cell leukemia immunoprecipitate EBV-related antigens. Leuk Res (1981) 0.85
Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis. Mod Pathol (1989) 0.85
Graft versus host disease following transfusion of normal blood products to patients with malignancies. J Surg Oncol (1987) 0.84
Epstein-Barr virus--associated lymphoproliferative lesions. Clin Lab Med (1988) 0.84
Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37. Hum Genet (1989) 0.84
X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma. Arch Pathol Lab Med (1981) 0.84
Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome. Int J Cancer (1982) 0.84
Pulmonary angiitis with atypical lymphoreticular infiltrates in Wiskott-Aldrich syndrome: possible relationship of lymphomatoid granulomatosis and EBV infection. Clin Immunol Immunopathol (1986) 0.83
Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis. Int J Cancer (1990) 0.83
The immune system of the nine-banded armadillo (Dasypus novemcinctus, Linn). Anat Rec (1975) 0.83
Humoral immunity of parasitized, malnourished children. Am J Trop Med Hyg (1976) 0.83
Oncological consequences of impaired immune surveillance against ubiquitous viruses. J Clin Immunol (1983) 0.83
Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. Am J Med (1991) 0.83
Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV. Microbiol Immunol (1986) 0.82
Simple assay for evaluation of Epstein-Barr virus specific cytotoxic T lymphocytes. J Immunol Methods (1995) 0.82
Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant hematopoietic cell lines. Leuk Res (1985) 0.82
Epstein-Barr virus and chronic lymphadenomegaly in male homosexuals with acquired immunodeficiency syndrome (AIDS). AIDS Res (1986) 0.82
Induction of antibody to asialo GM1 by spermatozoa and its occurrence in the sera of homosexual men with the acquired immune deficiency syndrome (AIDS). Clin Exp Immunol (1983) 0.82
Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model. Am J Pathol (1992) 0.82
Soluble interleukin 2 receptors in patients with malignant lymphoma. Arch Pathol Lab Med (1988) 0.82
Role of Epstein-Barr virus in acquired immune deficiency syndrome. Adv Exp Med Biol (1985) 0.81
Epstein-Barr virus in normal pregnant women. Am J Reprod Immunol (1982) 0.81
Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative disease. Am J Med Genet (1989) 0.81
A family study of pigeon breeders' disease. J Pediatr (1975) 0.81
Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study. Hum Pathol (1987) 0.81
Alpha-fetoprotein: its immunofluorescent localization in human fetal liver and hepatoma. Lab Invest (1971) 0.80
Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virus. Ann Intern Med (1986) 0.80
Primary brain lymphoma in the immunocompetent host: relation to Epstein-Barr virus. Mod Pathol (1990) 0.80
Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome. Cell Immunol (1986) 0.80